← Open Payments lookup

PAIGE GRIFFITH: Open Payments

NPI 1639636731 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$30,370 in 66 payments from 12 companies in 2025. Trend: 2023 $25,831 · 2024 $44,352 · 2025 $30,370

Speaker / faculty: $25,000Food & beverage: $2,567Consulting: $1,469Travel & lodging: $1,236Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP44$27,351
JAZZ PHARMACEUTICALS INC.1$1,075
Incyte Corporation3$545
Daiichi Sankyo Inc.3$362
Janssen Biotech, Inc.3$185
Bayer Healthcare Pharmaceuticals Inc.4$182
Genmab U.S., Inc.2$155
Syndax Pharmaceuticals, Inc.1$144
Fennec Pharmaceuticals, Inc.2$136
Exelixis Inc.1$123

Products named: ZIIHERA, ZYNYZ, DATROWAY, Epkinly, Nubeqa, Fyarro, RYBREVANT, Pemazyre.

Industry payments across MD — which companies pay providers there.